125 related articles for article (PubMed ID: 29629667)
41. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.
Zhan X; Qin W; Wang S; Zhao K; Xin Y; Wang Y; Qi Q; Mao Z
Anticancer Agents Med Chem; 2017; 17(6):821-831. PubMed ID: 27671311
[TBL] [Abstract][Full Text] [Related]
43. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.
Kamal A; Vijaya Bharathi E; Janaki Ramaiah M; Dastagiri D; Surendranadha Reddy J; Viswanath A; Sultana F; Pushpavalli SN; Pal-Bhadra M; Srivastava HK; Narahari Sastry G; Juvekar A; Sen S; Zingde S
Bioorg Med Chem; 2010 Jan; 18(2):526-42. PubMed ID: 20031423
[TBL] [Abstract][Full Text] [Related]
44. Novel pyrrolopyrimidines and triazolopyrrolopyrimidines carrying a biologically active sulfonamide moieties as anticancer agents.
Ghorab MM; Alsaisd MS; Nissan YM
Acta Pol Pharm; 2015; 72(1):65-78. PubMed ID: 25850202
[TBL] [Abstract][Full Text] [Related]
45. Novel 2-cyanoacrylamido-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as potent anticancer agents.
Sroor FM; Aboelenin MM; Mahrous KF; Mahmoud K; Elwahy AHM; Abdelhamid IA
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000069. PubMed ID: 32657455
[TBL] [Abstract][Full Text] [Related]
46. Novel Tetrahydrobenzo [b] Thiophene Compounds Exhibit Anticancer Activity through Enhancing Apoptosis and Inhibiting Tyrosine Kinase.
El-Metwally SA; Khalil AK; El-Naggar AM; El-Sayed WM
Anticancer Agents Med Chem; 2018; 18(12):1761-1769. PubMed ID: 30101717
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
Wang G; Peng Z; Zhang J; Qiu J; Xie Z; Gong Z
Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.
Ammar YA; Sh El-Sharief AM; Belal A; Abbas SY; Mohamed YA; Mehany ABM; Ragab A
Eur J Med Chem; 2018 Aug; 156():918-932. PubMed ID: 30096580
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and anticancer activity of some novel 2-phenazinamine derivatives.
Gao X; Lu Y; Fang L; Fang X; Xing Y; Gou S; Xi T
Eur J Med Chem; 2013 Nov; 69():1-9. PubMed ID: 23995213
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents.
Altıntop MD; Sever B; Özdemir A; Ilgın S; Atlı Ö; Turan-Zitouni G; Kaplancıklı ZA
Anticancer Agents Med Chem; 2018; 18(11):1606-1616. PubMed ID: 29745341
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
53. DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW PYRROLOAZEPINES WITH POTENTIAL AND SELECTIVE ANTITUMOR ACTIVITY.
Jaiash DA; Belal A; Abdelgawad MA; Abdellatif KR
Acta Pol Pharm; 2016; 73(2):359-68. PubMed ID: 27180428
[TBL] [Abstract][Full Text] [Related]
54. Ligand-Based Drug Design: Synthesis and Biological Evaluation of Substituted Benzoin Derivatives as Potential Antitumor Agents.
Sabbah DA; Ibrahim AH; Talib WH; Alqaisi KM; Sweidan K; Bardaweel SK; Sheikha GA; Zhong HA; Al-Shalabi E; Khalaf RA; Mubarak MS
Med Chem; 2019; 15(4):417-429. PubMed ID: 30207238
[TBL] [Abstract][Full Text] [Related]
55. Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation.
Eldehna WM; Abo-Ashour MF; Ibrahim HS; Al-Ansary GH; Ghabbour HA; Elaasser MM; Ahmed HYA; Safwat NA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):686-700. PubMed ID: 29560733
[TBL] [Abstract][Full Text] [Related]
56. Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
Wang L; Liu X; Duan Y; Li X; Zhao B; Wang C; Xiao Z; Zheng P; Tang Q; Zhu W
Chem Biol Drug Des; 2018 Jul; 92(1):1301-1314. PubMed ID: 29575727
[TBL] [Abstract][Full Text] [Related]
57. N-substituted pyrrole-based scaffolds as potential anticancer and antiviral lead structures.
Pegklidou K; Papastavrou N; Gkizis P; Komiotis D; Balzarini J; Nicolaou I
Med Chem; 2015; 11(6):602-8. PubMed ID: 25770917
[TBL] [Abstract][Full Text] [Related]
58. Eco-friendly Synthesis of Pyrido[2,3-d]pyrimidine Analogs and Their Anticancer and Tyrosine Kinase Inhibition Activities.
El-Naggar AM; Khalil AK; Zeidan HM; El-Sayed WM
Anticancer Agents Med Chem; 2017; 17(12):1644-1651. PubMed ID: 28403776
[TBL] [Abstract][Full Text] [Related]
59. Synthetic Diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylates Induce Apoptosis.
Ahn S; Lee Y; Park J; Lee J; Shin SY; Lee YH; Koh D; Lim Y
Med Chem; 2018; 14(8):851-862. PubMed ID: 29669502
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of Tolmetin Hydrazide-Hydrazones and Discovery of a Potent Apoptosis Inducer in Colon Cancer Cells.
Küçükgüzel ŞG; Koç D; Çıkla-Süzgün P; Özsavcı D; Bingöl-Özakpınar Ö; Mega-Tiber P; Orun O; Erzincan P; Sağ-Erdem S; Şahin F
Arch Pharm (Weinheim); 2015 Oct; 348(10):730-42. PubMed ID: 26287512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
